eurozone

Ignite It
5 min read • August 14, 2024

Medical Marijuana Imports In Germany Increase 51% YoY Following Reform, Cannabis Clubs Still Face Bureaucratic Challenges

Ignite It
3 min read • August 12, 2024

These 3 Cannabis Companies Hold Cultivation Licenses In Germany: A ~$1.8B Market Opportunity?

Ignite It
3 min read • August 12, 2024

‘The Whole World Is In Overdose,’ Says CEO Of Company Behind Cannabis Inhaler That Enables Controlled Dosing

Ignite It
3 min read • August 8, 2024

Danish Cannabis Company Stenocare To Launch ‘Innovative’ Medical Marijuana Oil In Germany

Ignite It
3 min read • August 8, 2024

German Medical Marijuana Producer DEMECAN Comes Close To $109M Valuation With New Funding Round Led By US-Based Investor

Ignite It
3 min read • August 5, 2024

Colorado Cannabis Company Projects $1.03M Revenue In Q2, Explores Opportunities In Germany

Ignite It
3 min read • August 1, 2024

Germany’s Cannabis Clubs Face Setbacks Amid Reg Hurdles, Christian Democrat Leader Wants To Reverse Marijuana Law

Ignite It
4 min read • July 31, 2024

Medical Marijuana Patients In Germany Benefit from 50% Price Reduction Thanks To Legalization, New Report

Ignite It
3 min read • July 30, 2024

Snoop Dogg Rolls Out First Cannabis Coffeeshop In Amsterdam: ‘It’s Only Right That I Bring S.W.E.D. Global To This Iconic City’

Ignite It
3 min read • July 29, 2024

German Cannabis Producer DEMECAN Receives Cultivation License Under Legalization Program, Sees Strong Revenue Growth (Updated)

Ignite It
4 min read • July 29, 2024

Medical Marijuana To Be More Widely Reimbursed In Germany, Hemp Bill Attracts Investors And More Cannabis News

Ignite It
2 min read • July 26, 2024

Aurora Ramps Up Medical Cannabis Production In Germany With Enhanced Licenses To Expand Portfolio

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.